Altibbi

Digital health company founded in Amman that combines a large library of Arabic medical content with phone, chat and video consultations with doctors. It raised a $44 million Series B in March 2022.

Industry: Arabic telehealth and medical content | Location: Dubai, United Arab Emirates | Founded: 2010 | Total Funding: USD 53M

About Altibbi

Altibbi is a digital health company serving Arabic speakers in the Middle East and North Africa. Its website describes an Arabic medical platform that connects patients and doctors for remote consultations by voice call and text chat through its apps and website and a library of more than two million pages of Arabic medical content. Wamda described it as UAE-based in 2022, and its HIPAA certificate gives an address in Dubai.

Altibbi was founded in Amman by Jalil Allabadi, its chief executive. Entrepreneur Middle East's 2017 coverage gives 2010 as the founding year and names Dr. Abdelaziz Allabadi and Ayman Allabadi as co-founders, while 2022 releases say 2011. In 2017 the company listed offices in Amman, Dubai and Gaza and users in 10 Arab countries. In 2022 it reported about 20 million unique visitors a month and more than 1,500 active doctors, and by November 2025 it said it had delivered more than six million consultations.

Its products are paid consultations with doctors by phone and text chat, sold by subscription and Sina, an AI health assistant offered through its app. The website states that Altibbi is licensed by the Saudi Ministry of Health and publishes a July 2024 certificate in which QRO Certification states that ALTIBBI FZ-LLC was independently assessed as compliant with HIPAA for its telemedicine services.

In November 2025 Altibbi was the digital health partner for Haleon's Healthy Saudi Smile oral health campaign in Saudi Arabia.

Altibbi raised $500,000 in 2014 and $2 million in 2015 from DASH Ventures and Middle East Venture Partners, then a $6.5 million round led by the same two investors in October 2017, which brought total funding to $8.5 million. In March 2022 it announced a $44 million Series B led by Foundation Holdings and Hikma Ventures, with Global Ventures and DASH Ventures also taking part, and said total funding had passed $50 million. It said the money would go to online pharmacy, diagnostics collection and machine learning, with growth in Saudi Arabia and Egypt.

No funding round after March 2022 has been found in public sources.

Leadership

Related News & Coverage